Cumberland pharmaceuticals reports third quarter 2023 financial results

Nashville, tenn. , nov. 7, 2023 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company, announced today that its product portfolio of fda-approved brands delivered combined revenues of $10.1 million during the third quarter of 2023 and $30.2 million year to date.

CPIX Ratings Summary

CPIX Quant Ranking